Stay updated on Iomab-B vs Conventional Care in Older AML Clinical Trial
Sign up to get notified when there's something new on the Iomab-B vs Conventional Care in Older AML Clinical Trial page.

Latest updates to the Iomab-B vs Conventional Care in Older AML Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision: v3.3.3 was added to the page history, and the HHS Vulnerability Disclosure link along with Revision: v3.3.2 were removed.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe page shows a revision update from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check46 days agoChange DetectedRemoval of the 'Notice Because of a lapse in government funding...' banner; it is a site-wide status message and does not impact study data or historical records. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check60 days agoChange DetectedThe new screenshot shows the same page with identical sections and data as the old screenshot, with only minor visual/UI differences. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check89 days agoChange DetectedCore content updated with a government funding status notice and NIH Clinical Center operating details, plus a version upgrade from v3.1.0 to v3.2.0.SummaryDifference11%

- Check96 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.3%

Stay in the know with updates to Iomab-B vs Conventional Care in Older AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Iomab-B vs Conventional Care in Older AML Clinical Trial page.